Stock screenerAll disclosures →
EDGAR →
GRAL
Conviction 70HealthcareScan · Mon, Aug 10, 2026GRAL$74.80+7.66%
ResistanceSupportVol 14Insider sellVol MA14 867.68K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price74.80
Change+7.66%
Gap-0.42%
Rel volume4.98×
Avg volume742.53K
Avg $ vol52.05M
SMA 2070.09
SMA 5066.99
SMA 20073.95
Price vs 50+11.67%
Price vs 200+1.15%
MA stackmixed
50/200 cross—
Supertrendup · 61.57
RSI (14)57
MACD hist0.09
MACD crossbull · 0d
Stoch %K / %D92 / 58
ADX (14)17
+DI / −DI24 / 24
RSI divergence—
MACD divergence—
ATR %+6.82%
ADR %6.54%
52w high116.06
52w low31.42
From 52w high-35.55%
Above 52w low+138.06%
New 52w highNo
SqueezeOn · 1d
Bollinger width19.47%
%B0.85
Donchian pos92.13%
Donchian high76.00
Donchian low60.76
AVWAP (52w high)62.54
vs AVWAP high+19.61%
AVWAP (52w low)69.01
vs AVWAP low+8.40%
OBV trendFlat
Chaikin MF (20)0.20
Today vs 20d4.98×
Avg vol (14d)867.67K
Avg vol (20d)742.53K
Avg $ vol (20d)52.05M
Market cap—
RS 3m (vs SPY)+4.73%
RS 6m (vs SPY)-40.25%
RS line new highNo
Trend template5/8
Technical rank46.9
1 week+6.45%
1 month+3.89%
3 months+21.35%
6 months-25.25%
1 year+126.94%
YTD-15.83%
P/E-7.60
P/B1.22
P/S21.08
P/FCF-10.34
EPS-11.11
Div yield—
ROE-16.06%
ROA-14.36%
Debt/Eq—
Current10.95
EV/EBITDA—
Gross margin—
Net margin-277.47%
Rev growth17.18%
EPS growth79.85%
Price target69.14
Target upside-0.45%
Analyst ratingHold
Institutional89.30%
Ent. value3.05B
Revenue44.69M
Net income-110.25M
Gross profit—
Free cash flow-299.92M
IndustrySERVICES-MEDICAL LABORATORIES
ExchangeNasdaq
Shares out42.92M
Employees910
ListedWed, Jun 12, 2024
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeB
Conviction70 / 100
Pattern quality—
Tech rank46.9 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance75.62
Support58.56
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in GRAL
No recent disclosed trades by Congress in GRAL. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in GRAL · 9 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
MIZELL STEVEN Director · Common Stock · 2026-07-15 | Grant | 268 | $20K | 2026-07-15 | 2026-07-16 |
SUMME GREGORY L Director · Common Stock · 2026-07-15 | Grant | 427 | $32K | 2026-07-15 | 2026-07-16 |
CHASE WILLIAM J Director · Common Stock · 2026-07-15 | Grant | 276 | $21K | 2026-07-15 | 2026-07-16 |
MIZELL STEVEN Director · Common Stock · 2026-06-18 | Grant | 5.49K | $350K | 2026-06-18 | 2026-06-22 |
CHASE WILLIAM J Director · Common Stock · 2026-06-18 | Grant | 5.49K | $350K | 2026-06-18 | 2026-06-22 |
Krevans Sarah Director · Common Stock · 2026-06-18 | Grant | 5.49K | $350K | 2026-06-18 | 2026-06-22 |
SUMME GREGORY L Director · Common Stock · 2026-06-18 | Grant | 5.49K | $350K | 2026-06-18 | 2026-06-22 |
Partridge Andrew John Chief Growth Officer · Common Stock · 2026-06-04 | Sell | 1.49K | $91K | 2026-06-04 | 2026-06-05 |
Ofman Joshua J. Chief Executive Officer · Common Stock · 2026-06-03 | Grant | 3.15K | $193K | 2026-06-03 | 2026-06-03 |
Ofman Joshua J. Chief Executive Officer · Common Stock · 2026-06-01 | Grant | 27.9K | $1.8M | 2026-06-01 | 2026-06-03 |
SEC filings
EDGAR filings in GRAL · 8 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.